In Brief: Ephedrine comments
This article was originally published in The Tan Sheet
Executive Summary
Ephedrine comments: FDA extends comment period on agency's proposed rule on dietary supplements containing ephedrine alkaloids by 75 days because of omissions in the administrative record. The former deadline closed Aug. 18; the new deadline for comments is Nov. 1. The rule, which appeared in the June 4 Federal Register, proposes an 8 mg per serving limit on ephedrine alkaloid-containing dietary supplements and would ban labeling that suggests more than 8 mg within a six-hour period or a daily intake of 24 mg or more ("The Tan Sheet" June 9, pp. 20-23)...